AI Analysis AI Analysis of INCY
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Green day on Monday for Incyte Corporation stock after gaining 0.0192%
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Oct 14, 2025 Gain 21.18%

The Incyte Corporation stock price gained 0.0192% on the last trading day (Monday, 17th Nov 2025), rising from $104.15 to $104.17. During the last trading day the stock fluctuated 2.04% from a day low at $103.85 to a day high of $105.97. The price has risen in 6 of the last 10 days and is up by 2.56% over the past 2 weeks. Volume fell on the last day by -647 thousand shares and in total, 1 million shares were bought and sold for approximately $142.86 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 21.65% during the next 3 months and, with a 90% probability hold a price between $111.55 and $132.81 at the end of this 3-month period.

INCY Signals & Forecast

The Incyte Corporation stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $106.02. On a fall, the stock will find some support from the long-term average at approximately $93.35. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, November 12, 2025, and so far it has fallen -3.78%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Incyte Corporation stock

Incyte Corporation finds support from accumulated volume at $101.57 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.12 between high and low, or 2.04%. For the last week, the stock has had daily average volatility of 2.58%.

Our recommended stop-loss: $99.71 (-4.28%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (INCY) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Incyte Corporation to open at $104.66, and during the day (based on 14 day Average True Range), to move between $102.44 and $105.90, which gives a possible trading interval of +/-$3.46 (+/-3.38%) up or down from last closing price. If Incyte Corporation takes out the full calculated possible swing range there will be an estimated 3.38% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $105.20 (0.99%) than the support at $101.57 (2.50%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Incyte Corporation stock A Buy?

Incyte Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.357 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $104.66 ( 0.474%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

INCY Performance

Trading levels for INCY

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 106.78 2.51%
R2 105.97 1.73%
R1 105.47 1.25%
Price 104.17
S1 103.85 -0.304%
S2 103.35 -0.784%
S3 102.54 -1.56%

Accumulated Volume Support & Resistance Levels

Level Price
R3 105.98 1.74%
R2 105.70 1.47%
R1 105.20 0.99%
Price 104.17
S1 101.57 -2.50%
S2 91.65 -12.02%
S3 86.53 -16.93%

FAQ

What is the symbol for Incyte Corporation Stock and on which exchange is it traded?
The symbol for Incyte Corporation is INCY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Incyte Corporation Stock?
Incyte Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Incyte Corporation Stock?
Incyte Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Incyte Corporation Stock.

What's the current price of Incyte Corporation Stock?
As of the end of day on the Nov 17, 2025, the price of an Incyte Corporation (INCY) share was $104.17.

What is the 52-week high and low for Incyte Corporation Stock?
The 52-week high for Incyte Corporation Stock is $109.29 and the 52-week low is $53.56.

What is the market capitalization of Incyte Corporation Stock?
As of the Nov 17, 2025, the market capitalization of Incyte Corporation is 20.451B.

When is the next earnings date for Incyte Corporation?
The upcoming earnings date for Incyte Corporation is Feb 09, 2026.
Click to get the best stock tips daily for free!
ABOUT INCYTE CORPORATION
Incyte
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE